Ligand Pharmaceuticals Inc (LGND)
Debt Ratio
51.76%
Quarterly · Period ending:
LGND Debt Ratio
Latest reported51.76%period ending
Latest reported51.76%period ending
LGND Quarterly Debt Ratio (8.10% → 51.76%)
Latest values, visible window
High-resolution chart · PNG
LGND debt ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Debt Ratio |
|---|---|
| 51.762% | |
| 29.5004% | |
| 28.9299% | |
| 30.5394% | |
| 0.6053% | |
| 0.4913% | |
| 0.7544% | |
| 0.7705% | |
| 0.8752% | |
| 0.6778% | |
| 0.7831% | |
| 0.8228% | |
| 1.5395% | |
| 10.9331% | |
| 11.5051% | |
| 10.84% | |
| 13.4363% | |
| 17.6622% | |
| 24.9991% | |
| 25.9554% | |
| 25.6637% | |
| 28.2602% | |
| 33.5036% | |
| 36.869% | |
| 37.0559% | |
| 38.3792% | |
| 43.493% | |
| 41.5122% | |
| 36.7833% | |
| 33.9213% | |
| 50.4676% | |
| 38.7504% | |
| 43.3885% | |
| 30.1519% | |
| 33.4608% | |
| 33.4508% | |
| 34.1597% | |
| 34.2608% | |
| 35.3915% | |
| 34.9688% | |
| 33.6192% | |
| 33.3616% | |
| 38.4643% | |
| 38.9019% | |
| 65.811% | |
| 75.4368% | |
| 76.0542% | |
| 71.2376% | |
| 2.7021% | |
| 5.4697% | |
| 8.699% | |
| 12.1709% | |
| 15.6371% | |
| 19.0173% | |
| 27.1226% | |
| 38.6325% | |
| 52.2802% | |
| 35.9997% | |
| 24.7536% | |
| 55.5395% | |
| 31.3689% | |
| 30.4704% | |
| 30.2426% | |
| 38.8121% | |
| 38.3928% | |
| 29.1236% | |
| 25.644% | |
| 49.0844% | |
| 44.8458% | |
| 41.842% | |
| 2.3372% | |
| 0.6033% | |
| 0.7774% | |
| 0.987% | |
| 1.2437% | |
| 1.276% | |
| 1.4216% | |
| 0.7225% | |
| 12.2391% | |
| 61.4288% | |
| 50.647% | |
| 50.73% | |
| 54.9617% | |
| 56.5338% | |
| 57.6018% | |
| 55.5752% | |
| 52.341% | |
| 60.3442% | |
| 59.5871% | |
| 59.0056% | |
| 57.2708% | |
| 56.9104% | |
| 72.5631% | |
| 65.2449% | |
| 58.1418% | |
| 13.5216% | |
| 6.0569% | |
| 47.1044% | |
| 120.9852% | |
| 119.3653% |